Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

/sup 125/I-Bolton-Hunter-8-methoxy-2-(N-propyl-N-propylamino)tetralin as a new selective radioligand of 5-HT1A sites in the rat brain. In vitro binding and autoradiographic studies

Journal Article · · J. Pharmacol. Exp. Ther.; (United States)
OSTI ID:5243663
In vitro binding assays with /sup 125/I-(8-methoxy-2-(N-propyl-N-(3'-iodo-4'-hydroxyphenyl)-propionamido -N'- propylamino) tetralin) (/sup 125/I-BH-8-MeO-N-PAT), a /sup 125/I-labeled derivative of the potent serotonin (5-HT) agonist 8-hydroxy-2-(di-n-propylamino)tetralin ((/sup 3/H)-8-OH-DPAT), showed that this compound recognized specific sites with nanomolar affinity for 5-HT and 5-HT1A ligands such as spiroxatrine, ipsapirone, buspirone and gepirone in rat hippocampal membranes. Comparison of the binding characteristics of /sup 125/I-BH-8-MeO-N-PAT with those of (/sup 3/H)-8-OH-DPAT revealed striking similarities: at the hippocampal level, both binding sites exhibited nanomolar affinity for their respective ligands and the same Bmax; their pharmacological profiles defined by the inhibition of each bound ligand by a series of 26 serotonin, dopamine- or norepinephrine-related agonists and antagonists were identical; and their regional distributions examined by membrane binding assays and autoradiography of labeled brain sections were highly correlated. These observations indicate that /sup 125/I-BH-8-MeO-N-PAT is the first /sup 125/I-reversible ligand for the selective labeling of 5-HT1A sites in the rat central nervous system.
Research Organization:
Institut National de la Sante et de La Recherche Medicale U. 288, Paris (France)
OSTI ID:
5243663
Journal Information:
J. Pharmacol. Exp. Ther.; (United States), Journal Name: J. Pharmacol. Exp. Ther.; (United States) Vol. 244:2; ISSN JPETA
Country of Publication:
United States
Language:
English